Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127815232 | 12781523 | 2 | F | 20070605 | 20160919 | 20160926 | 20160927 | EXP | GB-PFIZER INC-483010 | PFIZER | 50.00 | YR | F | Y | 0.00000 | 20160927 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127815232 | 12781523 | 1 | PS | VANCOMYCIN HCL | VANCOMYCIN HYDROCHLORIDE | 1 | Ophthalmic | 10 MG, UNK | U | 62911 | 10 | MG | POWDER FOR INJECTION | ||||||
| 127815232 | 12781523 | 2 | SS | ADRENALINE /00003901/ | EPINEPHRINE | 1 | Intraocular | 0.3 UNK, UNK | N | 0 | .3 | ML | |||||||
| 127815232 | 12781523 | 3 | SS | BETAMETHASONE. | BETAMETHASONE | 1 | Ophthalmic | UNK | U | 0 | |||||||||
| 127815232 | 12781523 | 4 | SS | CYCLOPENTOLATE. | CYCLOPENTOLATE | 1 | Intraocular | 1 DF,1% STRENGTH | U | 0 | |||||||||
| 127815232 | 12781523 | 5 | SS | PROXYMETACAINE HYDROCHLORIDE | PROPARACAINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 127815232 | 12781523 | 6 | SS | HYALURONATE SODIUM | HYALURONATE SODIUM | 1 | Ophthalmic | UNK | U | 0 | |||||||||
| 127815232 | 12781523 | 7 | SS | LIDOCAINE. | LIDOCAINE | 1 | Ophthalmic | UNK | U | 0 | |||||||||
| 127815232 | 12781523 | 8 | SS | LIDOCAINE. | LIDOCAINE | 1 | U | 0 | |||||||||||
| 127815232 | 12781523 | 9 | SS | NEOMYCIN | NEOMYCIN | 1 | Ophthalmic | UNK | U | 0 | |||||||||
| 127815232 | 12781523 | 10 | SS | OCUFEN | FLURBIPROFEN SODIUM | 1 | Ophthalmic | 0.03% | U | E46628 | 0 | ||||||||
| 127815232 | 12781523 | 11 | SS | PHENYLEPHRINE | PHENYLEPHRINEPHENYLEPHRINE HYDROCHLORIDE | 1 | Ophthalmic | 1DF,2.5% STRENGTH | U | 0 | |||||||||
| 127815232 | 12781523 | 12 | SS | POVIDONE-IODINE. | POVIDONE-IODINE | 1 | Ophthalmic | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127815232 | 12781523 | 1 | Eye irrigation |
| 127815232 | 12781523 | 2 | Eye irrigation |
| 127815232 | 12781523 | 3 | Postoperative care |
| 127815232 | 12781523 | 4 | Postoperative care |
| 127815232 | 12781523 | 5 | Perioperative analgesia |
| 127815232 | 12781523 | 6 | Perioperative analgesia |
| 127815232 | 12781523 | 7 | Anaesthesia |
| 127815232 | 12781523 | 8 | Cataract operation |
| 127815232 | 12781523 | 9 | Postoperative care |
| 127815232 | 12781523 | 10 | Preoperative care |
| 127815232 | 12781523 | 11 | Cataract operation |
| 127815232 | 12781523 | 12 | Cataract operation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127815232 | 12781523 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127815232 | 12781523 | Toxic anterior segment syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127815232 | 12781523 | 1 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 2 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 3 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 4 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 5 | 20070530 | 20070530 | 0 | |
| 127815232 | 12781523 | 6 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 7 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 9 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 10 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 11 | 20070505 | 20070505 | 0 | |
| 127815232 | 12781523 | 12 | 20070505 | 20070505 | 0 |